MedPath

Standardized needle therapy in LE

Conditions
lateral epicondylitis, treatment, injectables, RCT.
Registration Number
NL-OMON20120
Lead Sponsor
Amphia hospital Breda. OLVG Amsterdam. AMC Amsterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
165
Inclusion Criteria

Patients referred by their GP to the orthopaedic surgeon diagnosed with unilateral Lateral Epicondylitis lasting longer than 6 weeks

• Age between 18 and 65 years

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:

• Prior injection therapy (during this episode of LE), surgery or trauma at the affected elbow.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main study parameters are the changes in pain using a Visual Analog Scale (VAS, 0-100) (Bodian e.a. 2001) 5 months after treatment:<br><br /><br>- After provocation test; pain during resisted dorsiflexion of the wrist during full elbow extension
Secondary Outcome Measures
NameTimeMethod
Secondary study parameters are the changes in pain using a Visual Analog Scale (VAS, 0-100) compared to baseline 5 months after treatment and after 8 weeks and 1 year after treatment (at rest and after maximun grip strength), functional recovery, Quality adjusted life years and complications<br><br><br>
© Copyright 2025. All Rights Reserved by MedPath